2BB score and signals
C4 Therapeutics, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 69 | High |
| Momentum | 68 | Improving |
| Financial strength | 31 | Weak |
| Quality | 98 | Very Strong |
| Risk | 62 | High |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2015 |
| Employees | 104 |
| 52-week range | $1.69 – $5.17 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.2909 | — | $4.08M |
| 2026-11-04 | — | -0.205 | — | $9.00M |
| 2026-08-05 | — | -0.2309 | — | $4.08M |
| 2026-05-12 | -0.2 | -0.3794 | $6.15M | $3.40M |
Related companies
